Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
World J Orthop ; 14(4): 207-217, 2023 Apr 18.
Article in English | MEDLINE | ID: mdl-37155513

ABSTRACT

BACKGROUND: Radiocarpal dislocations are rare but potentially devastating injuries. Poorer outcomes are associated with inadequate or lost reduction, such as ulnar translocation, but no consensus exists on the ideal fixation technique. Dorsal bridge plate fixation has been described for various settings in the treatment of complex distal radius fractures and can be fixed distally to the second or third metacarpal, but its application for radiocarpal dislocations has not been established. AIM: To determine whether distal fixation to the second or third metacarpal matters. METHODS: Using a cadaveric radiocarpal dislocation model, the effect of distal fixation was studied in two stages: (1) A pilot study that investigated the effect of distal fixation alone; and (2) a more refined study that investigated the effect of described techniques for distal and proximal fixation. Radiographs were measured in various parameters to determine the quality of the reduction achieved. RESULTS: The pilot study found that focusing on distal fixation alone without changing proximal fixation results in ulnar translocation and volar subluxation when fixing distally to the second metacarpal compared with the third. The second iteration demonstrated that anatomic alignment in coronal and sagittal planes could be achieved with each technique. CONCLUSION: In a cadaveric radiocarpal dislocation model, anatomic alignment can be maintained with bridge plate fixation to the second metacarpal or the third metacarpal if the described technique is followed. When considering dorsal bridge plate fixation for radiocarpal dislocations, the surgeon is encouraged to understand the nuances of different fixation techniques and how implant design features may influence proximal placement.

2.
Orthopedics ; 36(9): e1155-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24025006

ABSTRACT

The purpose of this study was to determine differences in insertional articular trauma in infrapatellar tibial portal and suprapatellar portal intramedullary tibial nail insertion techniques. A cadaveric study was performed on 10 matched pairs of fresh-frozen adult cadaver lower extremities with intact extensor mechanisms. Two study groups with 10 limbs each were created: left lower limbs were treated with a standard medial parapatellar nailing portal and right lower limbs were treated with a suprapatellar tibial nailing portal. Start points were created under fluoroscopic guidance in anteroposterior and mediolateral planes. A start wire was placed and opening reaming was performed on the specimens using instrumentation specific to the nailing portal. Specimens were then dissected by medial parapatellar arthrotomy, revealing the intra-articular condition of the knee structures. The border of the tibial entry reamer hole was measured to the anterior horns of the menisci, anterior cruciate ligament root, and intermeniscal ligament using a digital caliper accurate to 0.02 mm. The structure was considered damaged if the structure was obviously damaged on visual inspection or if a measurement was less than 1 mm. Impact to intra-articular structures was numerically lower in the suprapatellar group (2/10) compared with the infrapatellar group (4/10), but the difference was not statistically significant between the 2 groups (P=.629). The suprapatellar portal approach to the tibial start point demonstrated a lower overall incidence of damage to intra-articular structures, but no significant statistical difference existed between the 2 treatment groups.


Subject(s)
Anterior Cruciate Ligament/surgery , Bone Nails , Fracture Fixation, Intramedullary/methods , Knee Injuries/surgery , Patella/injuries , Tibia/surgery , Tibial Fractures/surgery , Adult , Anterior Cruciate Ligament/diagnostic imaging , Cadaver , Fluoroscopy , Humans , Knee Injuries/diagnostic imaging , Patella/diagnostic imaging , Patella/surgery , Tibia/diagnostic imaging , Tibial Fractures/diagnostic imaging
3.
Clin Nutr ; 30(5): 668-71, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21477901

ABSTRACT

BACKGROUND & AIMS: Inflammation is pivotal in all phases of atherosclerosis. Dietary options which lower inflammatory biomarkers would be an attractive strategy to reduce risk from cardiovascular diseases and cancer. Indeed, fruit and vegetable intake or fruit juice consumption is associated with health and wellness. However, there is a paucity of data examining the effect of orange juice on biomarkers of inflammation in healthy volunteers. We have previously conducted the first placebo-controlled randomized studies examining the effect of sterol fortified orange juice or sterol fortified reduced calorie orange juice beverage supplementation (2 g sterols/day) compared to Placebo OJ or Placebo OJBev, and showed significant benefits on the lipid profile as well as significant reduction in hsCRP, the prototypic marker of inflammation and a cardiovascular risk marker. The aim of this study was to examine the effect of orange juice (OJ) or OJ beverage (Bev) alone and fortified with plant sterols (1g/240 ml juice or beverage twice a day) on pro-inflammatory cytokines and PAI-1, a marker of impaired fibrinolysis in healthy human volunteers. METHODS: In the first study, 72 healthy human volunteers received Placebo OJ or Sterol OJ and in the second study, 72 volunteers received OJBev or Sterol OJBev for 8 weeks and blood was drawn at baseline and following supplementation for 8 weeks. Biomarkers of Inflammation (IL-1b, IL-6, TNF, IL-8, IL-10) were assessed in serum using the BD Human Inflammatory Cytokine Cytometric Bead Array and PAI-1 activity was assessed in citrated plasma. RESULTS: OJ or OJBev alone failed to result in any significant effects on circulating cytokine levels or PAI-1 activity. There was a significant reduction in IL-1b with sterol fortified OJ (p < 0.05) compared to baseline. In addition, both sterol fortified OJ as well as sterol fortified OJBev resulted in significant reductions in serum IL-6 levels (p < 0.01). CONCLUSION: Thus, sterol fortified OJ and OJ Beverage are able to effectively lower biomarkers of inflammation in healthy human volunteers in addition to providing lipid profile benefits and may thus contribute to decreasing cardiovascular risk.


Subject(s)
Beverages , Citrus sinensis/chemistry , Dietary Supplements , Interleukin-1beta/blood , Interleukin-6/blood , Phytosterols/administration & dosage , Plasminogen Activator Inhibitor 1/blood , Adult , Aged , Beverages/analysis , Biomarkers/blood , Dietary Supplements/analysis , Double-Blind Method , Down-Regulation , Female , Fibrinolysis , Fruit/chemistry , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
4.
J Diet Suppl ; 7(2): 145-53, 2010 Jun.
Article in English | MEDLINE | ID: mdl-22435613

ABSTRACT

Several factors limit the absorption and bioavailability of vitamins. Vitamin C, a commonly used water-soluble supplement reduces the risk of disease. Vitamin B(12) is necessary for the development of RBC, growth, and nervous system. Vitamin B(12) deficiency is common among elderly. Thus, agents that improve bioavailability of vitamin C and B(12), especially in older individuals would be important. Aloe Vera is a botanical with immunomodulatory properties. Aloe is processed using the hand-filleted technique or whole leaf procedure. The aim of this study is to examine the effect of two different aloe vera preparations (aloe inner leaf gel, [AG] and aloe whole leaf decolorized gel, [AL]) compared to placebo on the bioavailability of vitamins, C and B(12), in healthy human volunteers in a randomized crossover trial. Subjects (n = 15) received in a random fashion either aloe whole leaf extract (AL with vitamins B(12), 1 mg and vitamin C 500 mg) or aloe fillet gel (AG with B(12) 1 mg and vitamin C 500 mg) or water (with vitamin B(12) 1 mg and vitamin C 500 mg). Blood was obtained fasting, followed by 1, 2, 4, 6, 8, and 24 hours postingestion of aloe/water. When given with vitamins C and B(12), AG significantly increased plasma oxygen radical absorbance capacity (ORAC) at both 4 and 24 hours and AL at 4 hours compared to baseline and placebo. AG significantly increased plasma vitamin C at 4, 6, 8, and 24 hours and AL at 4 and 6 hours compared to baseline and placebo (p <.01). Also, both aloes significantly increased serum vitamin B(12) levels at 1 and 2 hours compared to baseline and placebo (p <.01). Thus, AG and AL preparations are safe, well tolerated, and enhance the bioavailability of vitamins C and B(12) and antioxidant potential.


Subject(s)
Aloe , Antioxidants/pharmacology , Ascorbic Acid/blood , Blood Glucose/metabolism , Lipids/blood , Plant Extracts/pharmacology , Vitamin B 12/blood , Aged , Biological Availability , Gels , Humans , Middle Aged , Plant Leaves , Reactive Oxygen Species/metabolism , Reference Values
5.
Metab Syndr Relat Disord ; 6(2): 149-52, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18484901

ABSTRACT

BACKGROUND: The Metabolic Syndrome (MS) confers an increased risk for diabetes and cardiovascular disease. We previously showed that simvastatin has concomitant benefits in reducing low-density lipoprotein (LDL)-cholesterol and inflammation in MS subjects. The levels of plasminogen activator inhibitor 1(PAI-1), soluble P-selectin (sP-selectin), and soluble CD40 ligand (sCD40L) play an important role in the development and progression of atherosclerosis. Their levels are increased in the MS. The current study was to investigate the effects of simvastatin on PAI-1, sP-selectin, and sCD40 ligand. METHODS: Fifty subjects with MS were randomized into either placebo or simvastatin (40 mg/day) group for 8 weeks. Blood samples were obtained at baseline and at the end of the study. PAI-1 activity and sP-selectin and sCD40L levels were measured by enzyme-linked immunosorbent assay (ELISA). RESULTS: There was no baseline difference in any of the parameters studied. Compared to baseline, simvastatin significantly reduced (P < 0.05) the circulating PAI-1 activity (24.3 +/- 5.2 IU/mL at baseline vs. 21.4 +/- 3.9 IU/mL after 8 weeks of treatment). Simvastatin did not alter (P < 0.05) the levels of sP-selectin (111.4 +/- 35.9 ng/mL at baseline vs. 118.5 +/- 71.2 ng/mL after 8 weeks) or sCD40L (2.0 +/- 1.6 ng/mL at baseline vs. 1.5 +/- 1.0 ng/mL after 8 weeks). CONCLUSION: Our data indicate that simvastatin therapy has significant effects on the fibrinolytic system in MS subjects as evidenced in a reduction in PAI-1 activity.


Subject(s)
Metabolic Syndrome/metabolism , Plasminogen Activator Inhibitor 1/metabolism , Simvastatin/pharmacology , Anticholesteremic Agents/pharmacology , Atherosclerosis/diagnosis , Atherosclerosis/pathology , CD40 Ligand/biosynthesis , Cardiovascular Diseases , Cell Adhesion , Fibrinolysis , Humans , Inflammation , Ligands , Metabolic Syndrome/drug therapy , Models, Biological , P-Selectin/biosynthesis , Placebos , Risk
6.
J Clin Endocrinol Metab ; 93(2): 578-83, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18029454

ABSTRACT

CONTEXT: Type 1 diabetes (T1DM) is associated with increased cardiovascular mortality. It is a pro-inflammatory state as evidenced by increased circulating biomarkers and monocyte activity. The toll-like receptors (TLRs) are pattern recognition receptors, expressed abundantly on monocytes. TLR2 and TLR4 are important in atherosclerosis. However, there is a paucity of data examining TLR2 and TLR4 expression in T1DM and examining its contribution to the proinflammatory state. OBJECTIVE: Thus, we examined TLR2 and TLR4 expression in monocytes from T1DM patients compared with controls (n = 31 per group). SETTING: The study was performed at the University of California Davis Medical Center. PATIENTS: Healthy controls (n = 31) and T1DM patients (n = 31) were included in the study. RESULTS: TLR2 and TLR4 surface expression and mRNA were significantly increased in T1DM monocytes compared with controls. Downstream targets of TLR, nuclear factor kappaB, myeloid differentiation factor 88, Trif, and phosphorylated IL-1 receptor-associated kinase were significantly up-regulated in T1DM. Finally, the release of IL-1beta and TNF-alpha was significantly increased in monocytes from T1DM compared with controls and correlated with TLR2 and TLR4 expression (P < 0.005). In addition, TLR2 and TLR4 expression was significantly correlated to glycosylated hemoglobin, carboxymethyllysine, and nuclear factor kappaB (P < 0.02). CONCLUSION: Thus, we make the novel observation that TLR2 and TLR4 expression and signaling are increased in T1DM and contribute to the proinflammatory state.


Subject(s)
Diabetes Mellitus, Type 1/blood , Leukocytes, Mononuclear/metabolism , Toll-Like Receptor 2/biosynthesis , Toll-Like Receptor 4/biosynthesis , Adult , Blotting, Western , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/immunology , Female , Humans , Interleukin-1 Receptor-Associated Kinases/metabolism , Interleukin-1beta/metabolism , Leukocytes, Mononuclear/immunology , Male , Myeloid Differentiation Factor 88/metabolism , NF-kappa B/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Statistics, Nonparametric , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/immunology , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/immunology , Tumor Necrosis Factor-alpha/metabolism
7.
Clin Podiatr Med Surg ; 21(3): 393-406, vii, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15246146

ABSTRACT

Introduced in the early 1970s, total ankle arthroplasty offered patients with debilitating ankle arthritis reduction in pain and almost normal mobility at the ankle joint. The idea of replacing an arthritic ankle joint with a mobile ankle prosthesis was originally welcomed to replace ankle arthrodesis. Unfortunately, high failure rates of first-generation implants led many surgeons in the United States to recommend ankle arthrodesis as the best alternative. An improved understanding of ankle joint mechanics, implant material and design, and surgical technique has led to the development of several second-generation implants that are being used successfully throughout the world. As short-term, mid-term, and long-term results continue to be published, there has been a momentous change in the outlook of total ankle arthroplasty as a viable option to ankle arthrodesis.


Subject(s)
Ankle Joint/surgery , Arthroplasty, Replacement/methods , Joint Prosthesis , Arthroplasty, Replacement/instrumentation , Humans , Prosthesis Design
SELECTION OF CITATIONS
SEARCH DETAIL
...